ProgressImage ProgressImage
Wanbury Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 524212 border-img ISIN Demat INE107F01022 border-img Book Value 30.74 border-img NSE Symbol WANBURY border-img Div & Yield % 0 border-img Market Cap ( Cr.) 754.37 border-img P/E 15.05 border-img EPS 14.37 border-img Face Value 10
ParticularsMar 2025
()
Mar 2024
()
Mar 2023
()
Mar 2022
()
Mar 2021
()
Mar 2020
()
INCOME :       
Sales Turnover 599.51577.74499.65511.19392.52367.45
Excise Duty 0.000.000.000.000.000.00
Net Sales 599.51577.74499.65511.19392.52367.45
Other Income 3.490.900.9177.882.4083.78
Stock Adjustments -1.513.89-29.1324.797.20-5.99
Total Income 601.49582.53471.43613.86402.12445.24
EXPENDITURE :       
Raw Materials 292.96307.48274.31325.07228.53169.75
Power & Fuel Cost 24.2425.1720.5918.4117.1315.38
Employee Cost 104.2486.9281.0074.8164.1567.48
Other Manufacturing Expenses 13.7613.3211.4312.669.9813.77
Selling & Administrative Expenses 64.7858.7145.1655.3445.4955.36
Miscellaneous Expenses 21.7117.9315.4514.3616.4216.29
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 521.69509.54447.94500.65381.70338.02
Operating Profit 79.8172.9923.49113.1920.42107.23
Interest 36.9529.1821.3920.6123.0732.87
Gross Profit 42.8643.812.1092.58-2.6574.36
Depreciation 13.3113.0312.3811.459.759.68
Profit Before Tax 29.5530.78-10.2881.13-12.4064.68
Tax 5.860.000.000.002.270.00
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax -6.840.380.11-0.35-2.070.21
Reported Net Profit 30.5330.40-10.4081.47-12.6164.46
Extraordinary Items 1.370.49-0.3176.061.2182.62
Adjusted Net Profit 29.1629.91-10.095.41-13.82-18.16
Adjustment below Net Profit -0.38-0.590.260.80-0.44-0.46
P & L Balance brought forward -138.34-168.14-158.01-240.28-227.23-291.23
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down -108.19-138.34-168.14-158.01-240.28-227.23
Dividend 0.000.000.000.000.000.00
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 0.000.000.000.000.000.00
Dividend Per Share(Rs) 0.000.000.000.000.000.00
Earnings Per Share-Unit Curr 9.329.28-3.1824.94-5.0425.79
Earnings Per Share(Adj)-Unit Curr 9.329.28-3.1824.94-5.0425.79
Book Value-Unit Curr 16.266.70-2.260.57-52.23-47.14
Book Value(Adj)-Unit Curr 16.266.70-2.260.57-52.23-47.14

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
imsl-img
close
refresh